AIM
PFE icon

AXA Investment Managers’s Pfizer PFE Stock Holding History

AXA Investment Managers’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$51.2M Buy
+2,009,291
New +$49.6M 0.14% 139

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

AXA Investment Managers's PFE Position: Q3 2025 in Review

AXA Investment Managers opened a new position in Pfizer (PFE) in Q3 2025: 2,009,291 shares worth $51.2M. The stake represents 0.14% of the portfolio and ranks #139 among its holdings.

2,811 funds tracked by Wall St. Rank hold PFE as of Q3 2025.

  • AXA Investment Managers held 2,009,291 shares of Pfizer worth $51.2M as of Q3 2025.
  • Pfizer was a new AXA Investment Managers position in Q3 2025.
  • Pfizer made up 0.14% of AXA Investment Managers's portfolio in Q3 2025, its #139 holding.
  • 2,811 funds tracked by Wall St. Rank held Pfizer as of Q3 2025.

Based on AXA Investment Managers's 13F filing for Q3 2025, filed 14 Nov 2025.